Tatva Chintan Pharma Chem Limited (NSE:TATVA)

Tatva Chintan Pharma Chem Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 8, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	24,744	15,840	25,231	36,995	51,166	-
Market Cap Growth	9.34%	-37.22%	-31.80%	-27.70%	-	-
Enterprise Value	24,967	15,844	24,403	37,505	50,113	-
Last Close Price	1057.80	676.48	1075.32	1661.94	2296.74	-
PE Ratio	345.83	277.26	83.12	81.33	53.37	-
Forward PE	48.58	41.06	29.94	36.07	42.29	-
PS Ratio	6.28	4.14	6.41	8.73	11.80	-
PB Ratio	3.35	2.14	3.42	7.19	10.82	-
P/TBV Ratio	3.38	2.16	3.44	7.19	10.82	-
P/OCF Ratio	-	64.21	25.73	133.16	252.92	-
PEG Ratio	0.49	1.13	1.13	1.13	1.13	-
EV/Sales Ratio	6.33	4.14	6.20	8.85	11.56	-
EV/EBITDA Ratio	67.03	47.71	35.40	55.46	46.26	-
EV/EBIT Ratio	278.56	237.11	55.74	64.15	49.87	-
Debt / Equity Ratio	0.05	0.05	0.02	0.33	0.25	0.54
Debt / EBITDA Ratio	0.98	1.09	0.21	2.51	1.10	1.35
Asset Turnover	-	0.46	0.50	0.60	0.89	1.07
Inventory Turnover	-	1.44	1.16	1.40	1.67	2.32
Quick Ratio	-	1.07	1.48	0.54	0.73	0.84
Current Ratio	-	2.76	3.74	1.31	2.55	1.56
Return on Equity (ROE)	-	0.77%	4.85%	9.21%	30.00%	36.85%
Return on Assets (ROA)	-	0.51%	3.47%	5.16%	12.91%	13.34%
Return on Capital (ROIC)	0.73%	0.55%	3.81%	5.72%	14.79%	16.19%
Return on Capital Employed (ROCE)	-	0.90%	5.90%	11.20%	20.60%	30.60%
Earnings Yield	0.29%	0.36%	1.20%	1.23%	1.87%	-
FCF Yield	-	-3.26%	-1.21%	-4.74%	-1.35%	-
Dividend Yield	0.09%	0.15%	0.19%	0.12%	0.09%	-
Payout Ratio	-	81.88%	15.41%	9.75%	-	7.69%
Buyback Yield / Dilution	-1.02%	-2.20%	-3.27%	-3.10%	-7.03%	-
Total Shareholder Return	-0.92%	-2.05%	-3.08%	-2.98%	-6.94%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.